HERON THERAPEUTICS ($HRTX) is expected to release its quarterly earnings data on Monday, August 10th before market open, per Finnhub. Analysts are expecting revenue of $43,044,000 and earnings of $0.01 per share.
You can see Quiver Quantitative's $HRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HERON THERAPEUTICS Revenue
HERON THERAPEUTICS had revenues of $34.7M in Q1 2026. This is a decrease of -26.71% from the same period in the prior year.
You can track HRTX financials on Quiver Quantitative's HRTX stock page.
You can access data on HRTX stock through the Quiver Quantitative API.
EARLY ACCESS
Receive HRTX Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →
HERON THERAPEUTICS Hedge Fund Activity
We have seen 69 institutional investors add shares of HERON THERAPEUTICS stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 10,239,225 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,192,403
- ORBIMED ADVISORS LLC added 9,816,940 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,854,533
- CONGRESS PARK CAPITAL LLC removed 2,016,290 shares (-50.0%) from their portfolio in Q2 2026, for an estimated $860,552
- NEW YORK STATE COMMON RETIREMENT FUND removed 1,882,551 shares (-73.1%) from their portfolio in Q2 2026, for an estimated $803,472
- JANE STREET GROUP, LLC removed 1,367,891 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,094,449
- CITADEL ADVISORS LLC removed 1,335,776 shares (-63.8%) from their portfolio in Q1 2026, for an estimated $1,068,754
- PALE FIRE CAPITAL SE added 1,246,673 shares (+84.8%) to their portfolio in Q1 2026, for an estimated $997,463
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »
View the Zacks #1 Rank List
HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More
HERON THERAPEUTICS ($HRTX) is expected to release its quarterly earnings data on Monday, August 10th before market open, per Finnhub. Analysts are expecting revenue of $43,044,000 and earnings of $0.01 per share.
You can see Quiver Quantitative's $HRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HERON THERAPEUTICS Revenue
HERON THERAPEUTICS had revenues of $34.7M in Q1 2026. This is a decrease of -26.71% from the same period in the prior year.
You can track HRTX financials on Quiver Quantitative's HRTX stock page.
You can access data on HRTX stock through the Quiver Quantitative API.
HERON THERAPEUTICS Hedge Fund Activity
We have seen 69 institutional investors add shares of HERON THERAPEUTICS stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »